Published in World J Gastroenterol on December 01, 2001
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res (2009) 2.01
Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology (2010) 1.63
Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis (2011) 1.37
Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma. PLoS One (2013) 1.02
The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol (2006) 0.96
Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol (2003) 0.82
Input of microenvironmental regulation on colorectal cancer: role of the CCN family. World J Gastroenterol (2014) 0.82
BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells. PLoS One (2013) 0.81
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature (1998) 2.83
Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene (2000) 2.52
Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51
Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem (2000) 2.46
Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A (2001) 2.08
Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol (2000) 1.97
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer (1999) 1.89
Cross-talk between the proto-oncogenes Met and Ron. Oncogene (2000) 1.71
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem (1999) 1.58
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A (2001) 1.58
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54
Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res (1999) 1.48
HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res (2000) 1.47
Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst (1999) 1.44
Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology (2001) 1.29
Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis? Oncogene (2001) 1.26
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Cancer Res (2000) 1.23
c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol (2001) 1.16
Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem Biophys Res Commun (1999) 1.15
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene (1999) 1.14
Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res (1999) 1.13
Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am J Pathol (2000) 1.12
Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. J Biol Chem (2000) 1.11
Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J Biol Chem (1998) 1.11
Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res (2000) 1.05
Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Oncogene (1999) 1.04
Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion. J Cell Biol (1998) 1.04
The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol Biol Cell (1999) 1.03
Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem (2001) 1.03
The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Oncogene (1999) 1.02
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. Blood (2001) 0.99
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol (2000) 0.98
Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. J Biol Chem (1999) 0.97
Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol (2000) 0.97
NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Mol Cell Biol (1998) 0.93
Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling. Oncogene (2001) 0.92
Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun (2001) 0.92
Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer (2000) 0.90
Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells. Int J Cancer (1999) 0.90
Growth-factor-dependent migration of human lung-cancer cells. Int J Cancer (1999) 0.89
NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br J Cancer (2001) 0.85
Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells. J Cell Physiol (2001) 0.84
In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors. Cancer Res (2001) 0.84
Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Biochem Biophys Res Commun (2000) 0.83
Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells. Cell Growth Differ (1999) 0.83
Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. Endocrinology (1999) 0.82
Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers. Br J Cancer (2000) 0.81
Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cells. Hepatology (1998) 0.79
Hepatocyte growth factor and vitamin D cooperatively inhibit androgen-unresponsive prostate cancer cell lines. Endocrinology (2000) 0.78
Hepatocyte growth factor induces rat ovarian surface epithelial cell mitosis or apoptosis depending on the presence or absence of an extracellular matrix. Endocrinology (1999) 0.77
Crystal structure of a group I ribozyme domain: principles of RNA packing. Science (1996) 13.99
Crystal structure of a hepatitis delta virus ribozyme. Nature (1998) 7.07
Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science (2001) 4.79
Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA (2001) 3.55
RNA tertiary structure mediation by adenosine platforms. Science (1996) 3.40
The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J Mol Biol (1999) 3.25
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83
Phonon density of states of iron up to 153 gigapascals. Science (2001) 1.74
Organelle-specific Isozymes of Aspartate-alpha-Ketoglutarate Transaminase in Spinach Leaves. Plant Physiol (1976) 1.64
Spherosomes of Castor Bean Endosperm: MEMBRANE COMPONENTS, FORMATION, AND DEGRADATION. Plant Physiol (1980) 1.52
Structure of yeast regulatory gene LEU3 and evidence that LEU3 itself is under general amino acid control. Nucleic Acids Res (1987) 1.51
A general module for RNA crystallization. J Mol Biol (1998) 1.44
Potential metabolite markers of schizophrenia. Mol Psychiatry (2011) 1.35
Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology (1997) 1.26
Crystal structure of recombinant chicken triosephosphate isomerase-phosphoglycolohydroxamate complex at 1.8-A resolution. Biochemistry (1994) 1.21
Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats. World J Gastroenterol (2001) 1.19
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Direct pK(a) measurement of the active-site cytosine in a genomic hepatitis delta virus ribozyme. J Am Chem Soc (2001) 1.15
Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun (2004) 1.13
A novel, putative MEK kinase controls developmental timing and spatial patterning in Dictyostelium and is regulated by ubiquitin-mediated protein degradation. Genes Dev (1998) 1.10
Structure of Dicer and mechanistic implications for RNAi. Cold Spring Harb Symp Quant Biol (2006) 1.09
miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis (2013) 1.09
Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J Gastroenterol (2001) 1.08
Amino acid sequence analysis of the proteolytic cleavage products of the bovine immunodeficiency virus Gag precursor polypeptide. J Virol (1994) 1.06
The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci U S A (1996) 1.06
Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun (1995) 1.04
Evidence that intramolecular interactions are involved in masking the activation domain of transcriptional activator Leu3p. J Biol Chem (1997) 1.00
Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem (1998) 0.99
Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res (1995) 0.98
A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain. Eur J Pain (2015) 0.97
Hepatic resection for synchronous hepatic metastasis from gastric cancer. Eur J Surg Oncol (2013) 0.97
Molecular marker heterozygosity and hybrid performance in indica and japonica rice. Theor Appl Genet (1996) 0.96
Efficacy and safety of embolization in iatrogenic traumatic uterine vascular malformations. Clin Radiol (2012) 0.95
Improving follow-up after an abnormal pap smear: results from a quasi-experimental intervention study. J Womens Health Gend Based Med (2000) 0.95
Resource allocation and extracellular acid-base status in the sea urchin Strongylocentrotus droebachiensis in response to CO₂ induced seawater acidification. Aquat Toxicol (2012) 0.94
Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J (1996) 0.92
Stepwise improvements in catalytic effectiveness: independence and interdependence in combinations of point mutations of a sluggish triosephosphate isomerase. Biochemistry (1991) 0.92
Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm (Vienna) (2008) 0.92
Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver. Cell Biol Toxicol (1997) 0.92
Nuclear inelastic x-ray scattering of FeO to 48 GPa. Phys Rev Lett (2001) 0.91
A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation (1995) 0.91
Redundant and selective roles for erythropoietin receptor tyrosines in erythropoiesis in vivo. Blood (1998) 0.91
An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis (2015) 0.90
Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: evaluation with analysis of 72 patients. World J Surg (1996) 0.89
An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology (1995) 0.89
Cloning and targeted mutations of G alpha 7 and G alpha 8, two developmentally regulated G protein alpha-subunit genes in Dictyostelium. Mol Biol Cell (1994) 0.89
Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail. J Biol Chem (1999) 0.89
Crystal monochromator with a resolution beyond 10(8). J Synchrotron Radiat (2001) 0.88
Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo. Proc Natl Acad Sci U S A (1998) 0.88
Reconstruction and expression of chimeric anti-HBx antibody in Escherichia coli. J Cancer Res Clin Oncol (1997) 0.87
Development and properties of a wax ester hydrolase in the cotyledons of jojoba seedlings. Plant Physiol (1978) 0.87
[Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi (1994) 0.87
Association of ADHD with genetic variants in the 5'-region of the dopamine transporter gene: evidence for allelic heterogeneity. Am J Med Genet B Neuropsychiatr Genet (2008) 0.87
Molecular genetic analysis of signal transduction pathways controlling multicellular development in Dictyostelium. Cold Spring Harb Symp Quant Biol (1992) 0.86
Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. Hepatogastroenterology (1998) 0.86
Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens. J Cancer Res Clin Oncol (1996) 0.86
Antioxidant properties of phenolic diterpenes from Rosmarinus officinalis. Acta Pharmacol Sin (2001) 0.86
Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials. J Cancer Res Clin Oncol (1998) 0.85
Experimental asthma developed by room air contamination with cockroach allergen. Int Arch Allergy Immunol (1996) 0.85
Kinetic characterization and regulation of phosphoenolpyruvate-dependent methyl alpha-D-glucopyranoside transport by Salmonella typhimurium membrane vesicles. Proc Natl Acad Sci U S A (1983) 0.85
No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.84
First-order isostructural Mott transition in highly compressed MnO. Phys Rev Lett (2005) 0.84
Immunological characterization of the gag gene products of bovine immunodeficiency virus. J Virol (1992) 0.84
A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis. Dis Esophagus (2013) 0.83
Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20. Hepatogastroenterology (2000) 0.83
Nucleotide sequencing of HLA-DQ gene second exons in Chinese homozygous cells. Eur J Immunogenet (1992) 0.82
Authentication of Chinese crude drug, Gecko, by allele-specific diagnostic PCR. Planta Med (2001) 0.82
Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt, August 2013. Euro Surveill (2013) 0.82
Genetic evidence for an additional factor required for erythropoietin-induced signal transduction. Blood (1999) 0.82
Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: implications for pharmacogenomic association studies. Ann Hum Genet (2004) 0.82
Microchannels in conventional single-mode fibers. Opt Lett (2006) 0.81
Sequence variation and gene duplication at MHC DQB loci of baiji (Lipotes vexillifer), a Chinese river dolphin. J Hered (2005) 0.80
mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential. J Cancer Res Clin Oncol (1996) 0.80
Lack of correlation of vacA genotype, cagA gene of Helicobacter pylori and their expression products with various gastroduodenal diseases. Chin Med J (Engl) (2001) 0.80
The study on the expression of membrane HSP70 protein in H22 cell and its immunoprotective mechanism against carcinoma. J Exp Clin Cancer Res (1999) 0.80
Treatment of unresectable primary liver cancer: with reference to cytoreduction and sequential resection. World J Surg (1995) 0.80
Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma. Med Oncol Tumor Pharmacother (1991) 0.80
DRB, DQA, DQB and DPB nucleotide sequences of Saguinus oedipus B95-8. Eur J Immunogenet (1994) 0.80
Increased ROS generation and SOD activity in heteroplasmic tissues of transmitochondrial mice with A3243G mitochondrial DNA mutation. Genet Mol Res (2008) 0.80
Three decades' experience in surgery of hepatocellular carcinoma. Gan To Kagaku Ryoho (1997) 0.79
Overexpression, biophysical characterization, and crystallization of ribonuclease I from Escherichia coli, a broad-specificity enzyme in the RNase T2 family. Arch Biochem Biophys (2001) 0.79
Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection. Cancer (1990) 0.79
Fas activation reduces neutrophil adhesion to endothelial cells. J Leukoc Biol (2000) 0.79
Extrahepatic metabolism of 4-methylumbelliferone and lidocaine in the anhepatic rabbit. Drug Metab Dispos (1996) 0.78
[Sequencing of Cyt b gene fragments and PCR identification of "jinqian baihuashe" (Bungarus parvus) and its adulterants]. Yao Xue Xue Bao (1998) 0.78
Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype. J Cancer Res Clin Oncol (1996) 0.78
Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res (2001) 0.78
Chronic kidney disease: implications for the perioperative period. Minerva Anestesiol (2010) 0.78
New cubic phase of Li3N: stability of the N3- ion to 200 GPa. Phys Rev Lett (2005) 0.78
Transcriptomic profiles of Japanese medaka (Oryzias latipes) in response to alkalinity stress. Genet Mol Res (2012) 0.77
Performance of a general location model with an ignorable missing-data assumption in a multivariate mental health services study. Stat Med (1999) 0.77
Review of support systems used in the management of fulminant hepatic failure. Dig Dis (1996) 0.77
[A study on enzymatic activities of bronchoalveolar lavage fluid in patients with interstitial lung diseases]. Zhonghua Jie He He Hu Xi Za Zhi (1998) 0.77
Cytoreduction and sequential resection: a hope for unresectable primary liver cancer. J Surg Oncol (1991) 0.77
Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results. J Cancer Res Clin Oncol (1993) 0.77
[Cloning and sequencing of nm23-H3b, a new gene identified to nm23]. Zhonghua Yi Xue Za Zhi (1994) 0.77
Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA--in vitro and in vivo studies. J Cancer Res Clin Oncol (1997) 0.77
Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. Neoplasma (2014) 0.77